308 related articles for article (PubMed ID: 31306149)
21. Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis.
Pflüger MJ; Jamouss KT; Afghani E; Lim SJ; Rodriguez Franco S; Mayo H; Spann M; Wang H; Singhi A; Lennon AM; Wood LD
Pancreatology; 2023 Nov; 23(7):868-877. PubMed ID: 37230894
[TBL] [Abstract][Full Text] [Related]
22. Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms.
Chhoda A; Sharma A; Sailo B; Tang H; Ruzgar N; Tan WY; Ying L; Khatri R; Narayanan A; Mane S; De Kumar B; Wood LD; Iacobuzio-Donahue C; Wolfgang CL; Kunstman JW; Salem RR; Farrell JJ; Ahuja N
Clin Epigenetics; 2023 Feb; 15(1):28. PubMed ID: 36803844
[TBL] [Abstract][Full Text] [Related]
23. Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Al Efishat MA; Attiyeh MA; Eaton AA; Gönen M; Prosser D; Lokshin AE; Castillo CF; Lillemoe KD; Ferrone CR; Pergolini I; Mino-Kenudson M; Rezaee N; Dal Molin M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; Kingham TP; DeMatteo RP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Aug; 268(2):340-347. PubMed ID: 28700444
[TBL] [Abstract][Full Text] [Related]
24. Role of Ancillary Testing on Endoscopic US-Guided Fine Needle Aspiration Samples from Cystic Pancreatic Neoplasms.
Jhala N; Srimunta P; Jhala D
Acta Cytol; 2020; 64(1-2):124-135. PubMed ID: 31509835
[TBL] [Abstract][Full Text] [Related]
25. PANDA cyst-fluid analysis: eats, shoots and leaves?
Anderson MA; Kwon RS; Scheiman JM
Gastrointest Endosc; 2009 May; 69(6):1103-5. PubMed ID: 19410042
[No Abstract] [Full Text] [Related]
26. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue.
Laquière AE; Lagarde A; Napoléon B; Bourdariat R; Atkinson A; Donatelli G; Pol B; Lecomte L; Curel L; Urena-Campos R; Helbert T; Valantin V; Mithieux F; Buono JP; Grandval P; Olschwang S
World J Gastroenterol; 2019 Sep; 25(36):5530-5542. PubMed ID: 31576098
[TBL] [Abstract][Full Text] [Related]
27. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
O'Neill RS; Emmanuel S; Williams D; Stoita A
World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
[TBL] [Abstract][Full Text] [Related]
28. Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study.
Volckmar AL; Endris V; Gaida MM; Leichsenring J; Stögbauer F; Allgäuer M; von Winterfeld M; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Schirmacher P; Rudi J; Schmitz D; Stenzinger A
Genes Chromosomes Cancer; 2019 Jan; 58(1):3-11. PubMed ID: 30230086
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.
Simpson RE; Yip-Schneider MT; Flick KF; Wu H; Colgate CL; Schmidt CM
Pancreas; 2019 Sep; 48(8):1026-1031. PubMed ID: 31404023
[TBL] [Abstract][Full Text] [Related]
30. Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma.
Qin Y; Wu CW; Taylor WR; Sawas T; Burger KN; Mahoney DW; Sun Z; Yab TC; Lidgard GP; Allawi HT; Buttar NS; Smyrk TC; Iyer PG; Katzka DA; Ahlquist DA; Kisiel JB
Clin Cancer Res; 2019 Dec; 25(24):7396-7404. PubMed ID: 31527170
[TBL] [Abstract][Full Text] [Related]
31. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis.
van der Waaij LA; van Dullemen HM; Porte RJ
Gastrointest Endosc; 2005 Sep; 62(3):383-9. PubMed ID: 16111956
[TBL] [Abstract][Full Text] [Related]
32. Cyst fluid glucose: An alternative to carcinoembryonic antigen for pancreatic mucinous cysts.
Lopes CV
World J Gastroenterol; 2019 May; 25(19):2271-2278. PubMed ID: 31148899
[TBL] [Abstract][Full Text] [Related]
33. Commercial molecular panels are of limited utility in the classification of pancreatic cystic lesions.
Panarelli NC; Sela R; Schreiner AM; Crapanzano JP; Klimstra DS; Schnoll-Sussman F; Pochapin MB; Yantiss RK
Am J Surg Pathol; 2012 Oct; 36(10):1434-43. PubMed ID: 22982886
[TBL] [Abstract][Full Text] [Related]
34. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer.
Majumder S; Philip NA; Singh Nagpal SJ; Takahashi N; Mara KC; Kendrick ML; Smyrk TC; Zhang L; Levy MJ; Gleeson FC; Petersen BT; Pearson RK; Topazian MD; Vege SS; Chari ST
Am J Gastroenterol; 2019 Mar; 114(3):524-529. PubMed ID: 30413822
[TBL] [Abstract][Full Text] [Related]
35. Molecular Diagnostics in the Evaluation of Pancreatic Cysts.
Theisen BK; Wald AI; Singhi AD
Surg Pathol Clin; 2016 Sep; 9(3):441-56. PubMed ID: 27523971
[TBL] [Abstract][Full Text] [Related]
36. Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma.
Anderson BW; Suh YS; Choi B; Lee HJ; Yab TC; Taylor WR; Dukek BA; Berger CK; Cao X; Foote PH; Devens ME; Boardman LA; Kisiel JB; Mahoney DW; Slettedahl SW; Allawi HT; Lidgard GP; Smyrk TC; Yang HK; Ahlquist DA
Clin Cancer Res; 2018 Nov; 24(22):5724-5734. PubMed ID: 29844130
[No Abstract] [Full Text] [Related]
37. Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance.
Okada T; Mizukami Y; Ono Y; Sato H; Hayashi A; Kawabata H; Koizumi K; Masuda S; Teshima S; Takahashi K; Katanuma A; Omori Y; Iwano H; Yamada M; Yokochi T; Asahara S; Kawakubo K; Kuwatani M; Sakamoto N; Enomoto K; Goto T; Sasajima J; Fujiya M; Ueda J; Matsumoto S; Taniue K; Sugitani A; Karasaki H; Okumura T
J Gastroenterol; 2020 Dec; 55(12):1183-1193. PubMed ID: 32939577
[TBL] [Abstract][Full Text] [Related]
38. Clinical Management of Pancreatic Premalignant Lesions.
Søreide K; Marchegiani G
Gastroenterology; 2022 Feb; 162(2):379-384. PubMed ID: 34678216
[No Abstract] [Full Text] [Related]
39. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates.
Kisiel JB; Yab TC; Taylor WR; Chari ST; Petersen GM; Mahoney DW; Ahlquist DA
Cancer; 2012 May; 118(10):2623-31. PubMed ID: 22083596
[TBL] [Abstract][Full Text] [Related]
40. Technical feasibility, diagnostic yield, and safety of microforceps biopsies during EUS evaluation of pancreatic cystic lesions (with video).
Mittal C; Obuch JC; Hammad H; Edmundowicz SA; Wani S; Shah RJ; Brauer BC; Attwell AR; Kaplan JB; Wagh MS
Gastrointest Endosc; 2018 May; 87(5):1263-1269. PubMed ID: 29309781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]